@article{c79407649fc348598331495fab7b03de,
title = "Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus",
abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:. The objective of this review is to assess the short-term and long-term effectiveness and safety of transepithelial CXL compared with epithelium-off CXL for progressive keratoconus.",
author = "Kuo, {Irene C.} and Hawkins, {Barbara S.} and Mark Ren and Lindsley, {Kristina B.}",
note = "Funding Information: Cochrane Eyes and Vision US Project, supported by grant 1 U01 EY020522, National Eye Institute, National Institutes of Health, USA. National Institute for Health Research (NIHR), UK. Funding Information: * Richard Wormald, Co-ordinating Editor for the Cochrane Eyes and Vision (CEV) acknowledges financial support for his CEV research sessions from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. Funding Information: We thank Lori Rosman, Information Specialist for Cochrane Eyes and Vision (CEV), who created and will execute the electronic search strategies. We thank Peter Hersh, MD, medical moderator for the clinical studies which led to US Food and Drug Administration approval of corneal collagen crosslinking; and Andrew Morgenstern, OD, of the International Keratoconus Academy of Eye Care Professionals, for their critical review of the protocol. Publisher Copyright: Copyright {\textcopyright} 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",
year = "2020",
month = jan,
day = "2",
doi = "10.1002/14651858.CD013512",
language = "English (US)",
volume = "2020",
journal = "Cochrane Database of Systematic Reviews",
issn = "1465-1858",
publisher = "John Wiley and Sons Ltd",
number = "1",
}